Steven E. Gryn
Western University(CA)London Health Sciences Centre(CA)
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Pharmacogenetics and Drug Metabolism, Health Systems, Economic Evaluations, Quality of Life, Atrial Fibrillation Management and Outcomes, Blood Pressure and Hypertension Studies
Most-Cited Works
- → Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children(2018)578 cited
- → Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children(2020)575 cited
- → Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults(2017)321 cited
- → Interpatient Variation in Rivaroxaban and Apixaban Plasma Concentrations in Routine Care(2017)59 cited
- → Novel therapeutics in hypertriglyceridemia(2015)44 cited
- → Pharmacogenetics of Lipid-Lowering Agents: Precision or Indecision Medicine?(2016)42 cited
- → Relationships between Endogenous Plasma Biomarkers of Constitutive Cytochrome P450 3A Activity and Single‐Time‐Point Oral Midazolam Microdose Phenotype in Healthy Subjects(2015)30 cited
- → Pharmacogenomics, Lipid Disorders, and Treatment Options(2014)23 cited
- → Apixaban Concentrations with Lower than Recommended Dosing in Older Adults with Atrial Fibrillation(2019)21 cited
- → Ezetimibe plus simvastatin for the treatment of hypercholesterolemia(2015)20 cited